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Introduction: The aim of this review is to provide an overview of the use of biological
materials in the augmentation of the anal sphincter either as part of an overlapping
sphincter repair (OSR) or anal bulking procedure.
Methods: A systematic search of PubMed was conducted using the search terms “anal
bulking agents,” “anal sphincter repair,” or “overlapping sphincter repair.” Five studies
using biological material as part of an overlapping sphincter repair (OSR) or as an anal
bulking agent were identified.
Results: 122 patients underwent anal bulking with a biological material. Anorectal
physiology was conducted in 27 patients and demonstrated deterioration in maximum
resting pressure, and no significant change in maximum squeeze increment. Quality of
life scores (QoLs) demonstrated improvements at 6weeks and 6months, but this had
deteriorated at 12months of follow up. Biological material was used in 23 patients to carry
out an anal encirclement procedure. Improvements in QoLs were observed in patients
undergoing OSR as well as anal encirclement using biological material. Incontinence
episodes decreased to an average of one per week from 8 to 10 preoperatively.
Conclusion: Sphincter encirclement with biological material has demonstrated improve-
ments in continence and QoLs in the short term compared to traditional repair alone.
Long-term studies are necessary to determine if this effect is sustained. As an anal bulking
agent the benefits are short-term.
Keywords: fecal incontinence, anal sphincter repair, overlapping sphincter repair, anal encirclement, anal bulking,
biological material
INTRODUCTION
Fecal incontinence (FI) affects between 1 and 10% of adults in varying degrees. Current epidemi-
ological studies have shown that up to 1% of adults have regular episodes of FI that adversely
impacts on their quality of life (1). Treatment modalities vary from conservative, with the use
of anti-diarrheal medications such as loperamide and codeine, to non-operative interventions
such biofeedback strategies, to surgical management. Surgical options are usually indicated when
continence is affected secondary to an anatomic disruption, such as a sphincter weakness or defect
(2). Patients who have a history of colorectal surgery (dilatation), obstetric sphincter injury, or pelvic
irradiation are also prone to fecal seepage and soiling (3).
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TABLE 1 | Biologic materials augmenting the anal sphincter for the treatment of fecal incontinence.
Reference Study
design
No. of
patients
Age Sex
(M:F)
Patient characteristics Material used Follow-up
(months)
Outcome Complications LofE
ANAL BULKING
Kumar
et al. (16)
Case
series
17 NS 5:12 Idiopathic fecal incontinence
secondary to weakness of the internal
anal sphincter:9 incontinent following
hemorrhoidectomy: 3.
Following an internal sphincterotomy.
obstetric injury: 2. Following surgical
treatment for fistula in ano: 1
Glutaraldehyde
cross-linked
(GAX) collagen
8 (4–12) Mean resting pressures:
preop: mean 30 cm H2O,
Postop: 45 cm H2O
None 4
Squeeze pressures: were not significantly different
before
Preop: 125 cm H2O,
Postop: 130 cm H2O
Maeda
et al. (17)
RCT
(pilot)
10 68 (45–79)
median
1:9 Passive fecal incontinence due to
internal anal sphincter (IAS)
dysfunction
Bulkamid™: 5
Permacol™: 5
19
(14–22) 1
lost to f/u
Median St Mark’s incontinence score: baseline:
16 (11–24),
6weeks: 14 (3–18),
6months:15 (8–22)
None
Improved at
6/52 but
deteriorated at
6/12, No
difference
between
Bulkamid™
and
Permacol™
2
Maximum resting pressure (cm H2O):
baseline:28 (15–58),
6weeks: 27 (19–56),
6months: 22 (10–38)
(P<0.05, baseline vs. 6months)
Median maximum squeeze increment:
baseline: 36 (16–109),
6weeks: 44 (13–102),
6months: 38 (15–186) (P<0.32, baseline vs.
6months)
FIQL: (preop vs. postop),
Lifestyle score: median 3.10–3.50 (P<0.05),
Coping: 2.36–2.75 (P<0.05).
Depression: 2.42–3.70 (P<0.005).
Embarrassment: 1.67–1.84 (P<0.05).
SF-36: preop: median 29,
Postop: 100
Maslekar
et al. (15)
Case
Series
100 61 (36–82)
mean
30:70 Fecal incontinence:
Idiopathic 70%
Traumatic 15%
Neuropathic 10%
Mixed 5%
Permacol® Min 36,
10 lost to
f/U
Preop: median squeeze pressures 54.7
(21.1–112.2)
None 4
Median resting pressures 40.4 (18.1–89.9)
CCFIS Preop: median 14 (9–18),
6weeks: 6 (5–14),
36months: 8 (6–12)
38% repeat injection after first injection at a median
of 12months (4–16months). 15% required an
additional injection at a median of 18months
(14–20months) from first injection.
(Continued)
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Themost common surgical procedure performed for the direct
repair of an anatomic sphincter defect for FI is an overlapping
sphincter repair (OSR) (4). Repairing the ends of the sphincter in
an “overlapping” fashion has been shown to have slightly better
results in comparison to a direct end-to-end repair (4). OSR is
ideal for an isolated single defect (often obstetric trauma related)
and bulking is reported ideal for a reduced hemorrhoidal cushion:
anal canal ratio (5, 6). An anal encirclement, usually referred to as
a Thiersch procedure, is the insertion of a prosthesis around the
anal sphincter, thus narrowing the anal opening and is performed
in patients with rectal prolapse who have high operative risk
and/or extreme old age (7). Originally carried out using a silver
wire, but due to ulcers and other complications, newer sutures are
used including nylon, Dacron, Silastic, Teflon, and silicon rubber
materials have been described.
Passive FI results in fecal leakage and is more likely to be due to
internal sphincter damage (8). This can occur during childbirth
or as a complication from anal surgery, particularly following a
lateral sphincterotomy or hemorrhoidectomy (9–11).
Injecting bulking agents into the anal sphincter complex
is a relatively new modality for patients with passive FI or
mild–moderate incontinence (2). It is proposed that the bulking
agents act to augment the anal cushions, thus providing an
improved seal and therefore increasing the anal zone pressure
(12). Furthermore, bulking agents are believed to improve anal
canal symmetry and again, improve anal canal sealing (12).
Neuromodulation techniques have recently become the reference
standard for FI, but concerns persist regarding long-term
effectiveness, costs, and complications arising from implanted
devices. Sacral nerve stimulation has been used increasingly
for FI in patients with external anal sphincter defects, but it is
invasive and expensive (13).
The aimof this review is to provide an overviewof the biological
materials that have beenused to augment an overlapping sphincter
repair and as a bulking agent (14).
METHODS
A systematic search of PubMed was conducted using the search
terms “anal bulking agents,” “anal sphincter repair” or “overlapping
sphincter repair.” Titles, abstracts, and finally full texts were ana-
lyzed for studies reporting on the use of biological mesh. Inclusion
criteria were studies that utilized biological material for either
sphincter repair or as a bulking agent. Studies were excluded if
only syntheticmaterial was used. Furthermore, studies on patients
under the age of 18 were excluded as well as non-English language
studies, technical tips or duplicates series from the same research
group. Overall, the search yielded five studies for analysis after
the exclusion of review articles. The study characteristics are
presented (Table 1).
RESULTS
Anal Bulking
There were three studies (a case series of 100 patients, a case
series with 17 patients and an RCT pilot study with 10 patients)
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(15–17) where patients underwent anal bulking. Of these, 122
patients received a biological material as a bulking agent. Over-
all, 105 patients received additionally cross-linked porcine der-
mal collagen paste (Permacol™) and a further 17 received Glu-
taraldehyde cross-linked (GAX) collagen, a highly purified bovine
dermal collagen. Anorectal physiology was carried out in only
27 patients and demonstrated deterioration in maximum rest-
ing pressure, and no significant change in maximum squeeze
increment.
StMark’s incontinence score was used in the RCT of 10 patients
and demonstrated an improvement at 6 weeks, but deteriorated at
6-month follow up (17). The SF-36 quality of life scale showed
a significant improvement in the role of a physical score from
29 to 100 after the injections. Similarly the Cleveland Clinic
Florida Incontinence Score (CCFIS) was used in the second study
on 100 patients and demonstrated an improvement in scores at
6 weeks and 6months, but this had deteriorated at 12-month
follow up (15). Another study carried out anorectal physiology in
17 patients but did not use any scoring system (16). There were no
complications reported in any of the studies.
Sphincter Repair
One study with 10 patients used an additionally cross-linked
porcine dermal collagen (Permacol™) to augment an OSR (18).
A traditional OSR dissection was carried out and the Permacol™
implant sutured to the under surface of the two muscle arms.
Another study with 13 patients used porcine intestinal submu-
cosa (Surgisis©) to carry out an anal encirclement procedure
(19). A tunnel was created around the anal canal through which
the Surgisis©graft was passed through and tightened. Validated
incontinence scores such as the Fecal Incontinence Severity Index
(FISI), Wexner, CCFIS and Fecal Incontinence Quality of Life
(FIQL) have been used to assess outcome. Improvements in FISI,
CCFIS and two sub scales of FIQL (coping/behavior and embar-
rassment) were observed in the group of patients undergoing OSR
(18). Furthermore, the FISI, Wexner score and all components of
FIQL score (lifestyle, coping/behavior, depression and embarrass-
ment) showed an improvement following anal encirclement using
biological material (19). Incontinence episodes decreased to an
average of one per week from8 to 10 preoperatively and there were
no complications reported.
DISCUSSION/SUMMARY
There are many different methods to improve symptoms of FI
and despite limited evidence; they have been adopted to varying
degrees. Agents such as autologous fat were first injected into the
anal canal to create bulk and resistance in 1995 (20). Since then,
other agents have been injected into the anal canal including
polytetrafluoroethylene, carbon-coated zirconium oxide beads
(Durasphere) and dextranomer microspheres in non-animal sta-
bilized hyaluronic acid gel (NASHA) hydrogel cross-linked with
polyacrylamide to name but a few (21) biologic materials are
relatively new in comparison and their use is becoming more
widespread. However, as the literature search above demonstrates,
the evidence advocating their use is limited. There is only one
pilot study for a controlled trial that randomized five patients to
receive a biological injectable agent and five to receive a synthetic
injectable agent (17) and the remainder are small case series
of low level evidence. Short-term outcomes are promising and
show some improvement in incontinence scores, but only half the
studies used patient reported outcomes in the form of the FIQL
scale. With regards to anal bulking with biologic material; there
is an initial improvement but this improvement does not appear
to be sustained at 12-month follow up. It was postulated that
the operative technique may play an important role as biological
agents injected sub mucosally, proximal to the dentate line, had
better outcomes than agents injected via the trans-sphincteric
route (22). Long-term follow up data is required in the form of
prospective controlled trials. Outcomes are poor in comparison
to NASHA DX, which has high quality RCT evidence to support
its use. Anal bulking may offer some improvement to a select
subgroup of patients, but NASHA DX should be the agent of
choice. The use of biologics, especially given the cost, cannot be
justified.
Anal encirclement with a prosthetic sling of silicone, which
aims to reinforce the repair and the damaged external anal sphinc-
ter muscle has been demonstrated to have similar outcomes to
alternative surgical procedures, although a high risk of breakage
and fecal impaction (23, 24). Only one study was identified using
biological material for anal encirclement and did not report any
complications. In the small group analyzed, patients benefited
from augmentation of the external anal sphincter, but long-term
follow up is required to determine if this benefit is sustained (19).
Finally, OSR using biological tissue does not appear add mor-
bidity. Sphincter augmentation has been in significant improve-
ment in continence and quality of life scores (QoLs) compared
with the preoperative scores in the short term over traditional
repair (18). Long-term studies are necessary to determine if this
effect is sustained.
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APPENDIX
BioMESH STUDY GROUP
Ferdinand Köckerling (Chairman), Stavros Antoniou, René
Fortelny, Frank A. Granderath, Markus Heiss, Franz Mayer, Marc
Miserez, Agneta Montgomery, Salvador Morales-Conde, Filip
Muysoms, Alexander Petter-Puchner, Rudolph Pointner, Neil
Smart, Marciej Smietanski, and Bernd Stechemesser.
AIM
The BioMesh StudyGroup has set itself the task of identifying how
best to use biological meshes for the various indications. The first
step toward achieving that goal is to compile systematic reviews
of the different indications on the basis of the existing literature.
The available literature sources will be evaluated in accordance
with the Oxford Centre for Evidence-based Medicine-Levels of
Evidence (March 2009). Next, based on the review findings, corre-
sponding Statements and Recommendations are to be formulated
in a Consensus Conference for the use of biological meshes for the
different indications. The findings of the Consensus Conference
are then to be summarized for a joint publication. This present
publication is part of the project undertaken by the BioMesh Study
Group.
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